
Reset all filters
01 1Biocon Limited
02 2BrightGene Bio-Medical Technology Co., Ltd.
03 1Concord Biotech Limited
04 1North China Pharmaceutical Huasheng Co. Ltd.
05 1Teva Pharmaceutical Works Private Limited Company
Reset all filters
01 4Fidaxomicin
02 1Fidaxomicin Crystalline
03 1Fidaxomycin
Reset all filters
01 2China
02 2India
03 1Israel
04 1Blank
NDC Package Code : 65727-027
Start Marketing Date : 2009-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62227-003
Start Marketing Date : 2014-03-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68254-0022
Start Marketing Date : 2023-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55500-0007
Start Marketing Date : 2017-02-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6kg/6kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1054
Start Marketing Date : 2013-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62227-027
Start Marketing Date : 2025-06-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
85
PharmaCompass offers a list of Fidaxomicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fidaxomicin manufacturer or Fidaxomicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fidaxomicin manufacturer or Fidaxomicin supplier.
PharmaCompass also assists you with knowing the Fidaxomicin API Price utilized in the formulation of products. Fidaxomicin API Price is not always fixed or binding as the Fidaxomicin Price is obtained through a variety of data sources. The Fidaxomicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clostomycin B1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clostomycin B1, including repackagers and relabelers. The FDA regulates Clostomycin B1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clostomycin B1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clostomycin B1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clostomycin B1 supplier is an individual or a company that provides Clostomycin B1 active pharmaceutical ingredient (API) or Clostomycin B1 finished formulations upon request. The Clostomycin B1 suppliers may include Clostomycin B1 API manufacturers, exporters, distributors and traders.
click here to find a list of Clostomycin B1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clostomycin B1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clostomycin B1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clostomycin B1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clostomycin B1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clostomycin B1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clostomycin B1 suppliers with NDC on PharmaCompass.
We have 5 companies offering Clostomycin B1
Get in contact with the supplier of your choice: